IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹902 Cr | ₹614 Cr | ₹190 Cr | ₹290 Cr | ₹313 Cr |
What is the latest Total Non-Current Liabilities ratio of IPCA LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹902 Cr |
Mar2022 | ₹614 Cr |
Mar2021 | ₹190 Cr |
Mar2020 | ₹290 Cr |
Mar2019 | ₹313 Cr |
How is Total Non-Current Liabilities of IPCA LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹902 Cr | 46.89 | |
Mar2022 | ₹614 Cr | 223.62 | |
Mar2021 | ₹190 Cr | -34.66 | |
Mar2020 | ₹290 Cr | -7.37 | |
Mar2019 | ₹313 Cr | - |
Compare Total Non-Current Liabilities of peers of IPCA LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IPCA LABORATORIES | ₹32,668.9 Cr | -2.3% | -3.2% | 87% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹370,757.0 Cr | 1.6% | -3.7% | 60% | Stock Analytics | |
CIPLA | ₹109,559.0 Cr | -2% | -4.6% | 49.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,416.0 Cr | -0.9% | 4.2% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,088.9 Cr | -2.1% | -0.9% | 89.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,939.0 Cr | -3.1% | -4.7% | 21.6% | Stock Analytics |
IPCA LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IPCA LABORATORIES | -2.3% |
-3.2% |
87% |
SENSEX | -0.6% |
-2.1% |
18.4% |
You may also like the below Video Courses